Dehydroepiandrosterone (DHEA), Eight Specimens
Use
The Dehydroepiandrosterone (DHEA), Eight Specimens test is used to assess the levels of DHEA in the body across multiple time points. This test is particularly useful for evaluating adrenal gland function and can aid in diagnosing endocrine disorders such as adrenal insufficiency or overproduction. By measuring the levels of DHEA before and after administering a drug or treatment, healthcare providers can gain insights into the adrenal response and better understand the patient's hormonal status.
Special Instructions
This test requires the collection of multiple specimens at different time points: an initial baseline sample followed by additional samples after administering a treatment such as a drug (pill or shot) or glucola. It is crucial to only perform this series if a treatment is given after the first sample draw. Clinicians should be contacted to confirm the necessity of the series before sample collection.
Limitations
The test has limitations in terms of interpreting DHEA levels as a standalone measure. Results may vary based on the individual's age, sex, and timing of specimen collection. Additionally, the test does not provide information on specific adrenal disorders without correlation to clinical symptoms and additional diagnostic testing. Being an in-house developed assay, the test's performance characteristics were determined by Labcorp, but it is not cleared or approved by the FDA.
Methodology
Other
Biomarkers
LOINC Codes
- 2193-1
- 12590-6
- 12591-4
- 12592-2
- 12593-0
- 12594-8
- 16732-0
- 59840-9
Result Turnaround Time
4-6 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided
Collection Instructions
Collect an initial tube for baseline and additional tubes after administering a treatment. Refer to the Endocrine Appendix of the LabCorp Directory of Services for instructions on multiple specimen collection.